Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 29 citing Holtz: Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors.... (0.10 sec) 

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug …


YS Kwon, YH Kim, GY Suh, MP Chung, H Kim, … - Clinical Infectious Diseases, 2008 - UChicago Press
Featured in Reuters-USE_THIS "Dual HIV/TB infection common in S. African
infants" December 29, 2008 # High Incidence of Tuberculosis among HIV-Infected
Infants: Evidence from a South African Population-Based Study Highlights ...
Cited by 27 - Related articles - All 5 versions

A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant …


SK Katiyar, S Bihari, S Prakash, M Mamtani, H … - The International Journal of Tuberculosis and Lung …, 2008 - ingentaconnect.com
Page 1. INT J TUBERC LUNG DIS 12(2):139–145 © 2008 The Union A randomised
controlled trial of high-dose isoniazid adjuvant therapy ...
Cited by 18 - Related articles - BL Direct - All 12 versions

Parametric survival analysis and taxonomy of hazard functions for the generalized gamma …


C Cox, H Chu, MF Schneider, A Muñoz - Statistics in medicine, 2007 - ncbi.nlm.nih.gov
The widely used Cox proportional hazards regression model for the analysis of
censored survival data has limited utility when either hazard functions
themselves are of primary interest, or when relative times instead of ...
Cited by 18 - Related articles - BL Direct - All 3 versions

Management of multidrug-resistant tuberculosis: update 2007


WW Yew, CC Leung - Respirology, 2008 - interscience.wiley.com
Abstract: Multidrug-resistant tuberculosis (MDR-TB) with bacillary resistance to
at least isoniazid and rifampicin in vitro is a worldwide phenomenon. Hot spots
of the disease are found scattered in different continents. Prevention of ...
Cited by 14 - Related articles - BL Direct - All 4 versions

Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary …


C Babb, L Van der Merwe, N Beyers, C … - Tuberculosis, 2007 - Elsevier
A cohort of pulmonary tuberculosis (TB) patients in a South African admixed
population was investigated to determine if the vitamin D receptor gene (VDR)
polymorphisms FokI, ApaI, and TaqI are associated with TB susceptibility or ...
Cited by 12 - Related articles - All 10 versions

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic …


EW Orenstein, S Basu, NS Shah, JR Andrews, … - The Lancet Infectious Diseases, 2009 - Elsevier
Multidrug-resistant (MDR) tuberculosis is a growing clinical and public-health
concern. To evaluate existing evidence regarding treatment regimens for MDR
tuberculosis, we used a Bayesian random-effects meta-analysis of the ...
Cited by 10 - Related articles - All 24 versions

Control and prevention of healthcare-associated tuberculosis: the role of respiratory …


H Humphreys - Journal of Hospital Infection, 2007 - Elsevier
Although the prevalence of tuberculosis continues to decline in most developed
countries, the risk of healthcare-associated tuberculosis, remains for patients
or healthcare staff. Outbreaks of healthcare-associated tuberculosis are ...
Cited by 12 - Related articles - All 8 versions

Management of extensively drug-resistant tuberculosis in Peru: cure is possible


CA Bonilla, A Crossa, HO Jave, CD Mitnick, … - Plos One, 2008 - pubmedcentral.nih.gov
Conceived and designed the experiments: CB AC HJ CM RJ CH LA AM JNB MZ EJ.
Performed the experiments: CB AC HJ RJ CH LA AM JNB. Analyzed the data: CB AC HJ
CM RJ CH LA AM JNB MZ. Contributed reagents/materials/analysis tools: CB AC ...
Cited by 9 - Related articles - All 6 versions

Key issues in multidrug-resistant tuberculosis


B Chakrabarti, PDO Davies - Future Microbiol., 2007 - Future Medicine
Tuberculosis is responsible for 2 million deaths worldwide and 8 million new
cases are reported globally every year. Multidrug-resistant tuberculosis
(MDR-TB) is an emerging and difficult public health problem worldwide. In ...
Cited by 7 - Related articles - BL Direct - All 5 versions

Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory …

- fda.gov [PDF] 
LV Sacks, RE Behrman - Tuberculosis, 2008 - Elsevier
Simplifying and shortening treatment for drug-sensitive tuberculosis and
providing new treatment options for drug-resistant tuberculosis constitute two
principal goals in the development of novel drugs for tuberculosis. ...
Cited by 4 - Related articles - All 18 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google